News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Insulin Caught In The Crossfire Of Drug Pricing Debate



11/18/2016 7:14:14 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Recent debates over skyrocketing drug prices are directly impacting diabetes patients, but it’s an extremely complex situation said Aaron Kowalski, chief mission officer at the Juvenile Diabetes Research Fund (JDRF).

At the heart of the battle is insulin, a vital therapy for more than 6 million Americans. Three major pharmaceutical companies dominate the market, including Novo Nordisk.

The Danish Pharmaceutical company ceased development of its experimental insulin pill in October — a move attributed to poor reimbursement potential.

Read at MedCity News


comments powered by Disqus
 
 
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES